SC 13G

Company

Aurinia Pharmaceuticals Inc.

Filed

July 5, 2017

Accession Number

0001140361-17-027184

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →